BETA · In development—Rankings and features improve every week.Spotted an error?Tell us →
Sign in / Register

Natera

Listed · Nasdaq · NTRANot ranked by Uback

Uback segment Healthtech › Medtech › In-vitro diagnostics

Cell-free DNA tests for prenatal screening, transplant monitoring and cancer recurrence.

Market value on the ranking date

Market capUSD 28bn · Mar 2026
ListingNasdaq · NTRA
CountryUnited States

Published figures

Natera and its private challengers · In-vitro diagnostics

Non-listed in-vitro diagnostics companies ranked by Uback, with Natera and the other listed pure players shown in grey at their market value on the ranking date (28 Oct 2026). Listed companies are never ranked.

#CompanyValuation
—NateraUnited States · Listed · Nasdaq · NTRAUSD 28bnMarket cap · Mar 2026
—Guardant HealthUnited States · Listed · Nasdaq · GHUSD 12bnMarket cap · Mar 2026
—GRAILUnited States · Listed · Nasdaq · GRALUSD 7.1bnMarket cap · Oct 2026
1Function HealthUnited States≈ USD 2.5bnUnicorn · AI estimateBack
—FreenomeUnited States · Listed · Nasdaq · FRNMUSD 1.37bnMarket cap · Oct 2026
2Delfi DiagnosticsUnited States≈ USD 1.2bnUnicorn · AI estimateBack
3EverlywellUnited States≈ USD 900MHundreds of M$ · AI estimateBack
4LetsGetCheckedIreland≈ USD 770MHundreds of M$ · AI estimateBack
5Harbinger HealthUnited States≈ USD 520MHundreds of M$ · AI estimateBack
6KariusUnited States≈ USD 520MHundreds of M$ · AI estimateBack
7Truvian HealthUnited States≈ USD 380MHundreds of M$ · AI estimateBack
8MirvieUnited States≈ USD 310MHundreds of M$ · AI estimateBack
9InflammatixUnited States≈ USD 290MHundreds of M$ · AI estimateBack
10deepullSpain≈ USD 290MHundreds of M$ · AI estimateBack
11Visby MedicalUnited States≈ USD 280MHundreds of M$ · AI estimateBack
12HealthiansIndia≈ USD 280MHundreds of M$ · AI estimateBack
13Orange HealthIndia≈ USD 260MHundreds of M$ · AI estimateBack
14Redcliffe LabsIndia≈ USD 220MHundreds of M$ · AI estimateBack
15CraifJapan≈ USD 170MHundreds of M$ · AI estimateBack
16AbionicSwitzerland≈ USD 110MHundreds of M$ · AI estimateBack
17SpotitEarlyIsrael≈ USD 100MHundreds of M$ · AI estimateBack
18PrenosisUnited States≈ USD 100MHundreds of M$ · AI estimateBack
19LucisFrance≈ USD 100MHundreds of M$ · AI estimateBack
20LucenceSingapore≈ USD 100MHundreds of M$ · AI estimateBack
21Day Zero DiagnosticsUnited States≈ USD 83MTens of M$ · AI estimateBack
22TethisItaly≈ USD 80MTens of M$ · AI estimateBack
23Ilara HealthKenya≈ USD 19MTens of M$ · AI estimateBack
24OncoliqArgentina≈ USD 15MTens of M$ · AI estimateBack
25RedbirdGhana≈ USD 7.7MMillions $ · AI estimateBack

Declare an interest in In-vitro diagnostics   Full In-vitro diagnostics ranking →

Figures as published by the company and market data, at the date shown.

Uback is a content publisher. It ranks non-listed companies only and gives no opinion on listed companies: the figures above are facts as published, at the date shown, never a recommendation. No intention can be declared on a listed company. Method